Targeting dopamine pathways with hybrid molecules: Emerging outlook for cancer treatment

Area of Science:

• Biochemistry and Molecular Biology
• Pharmacology and Therapeutics
• Nanomedicine

Background:

• Dopamine (DA) signaling influences critical cellular processes like growth, survival, and receptor signaling.
• Emerging therapeutic strategies integrate DA modulation with receptor co-targeting and targeted drug delivery.

Purpose of the Study:

• To review advances in hybrid constructs targeting DA pathways.
• To explore the mechanistic rationale behind these hybrid systems.
• To identify biological and translational challenges for clinical development.

Main Methods:

• Review of current literature on DA-pathway-targeting hybrid constructs.
• Analysis of diverse molecular formats including peptide chimeras and DA-functionalized nanomaterials.
• Examination of preclinical evidence and potential therapeutic benefits.

Main Results:

• Hybrid constructs demonstrate potential for enhanced pharmacologic precision and reduced off-target effects.
• Multifunctional systems include peptide chimeras and DA-nanomaterials.
• Preclinical data suggests improved intracellular accumulation.

Conclusions:

• Hybrid therapeutic platforms offer enhanced precision in DA-related signaling modulation.
• Significant biological and translational hurdles must be addressed for clinical application.
• Further development is crucial for realizing the therapeutic potential of these advanced constructs.